|
A HIGH-RESOLUTION RECOMBINATION MAP OF THE HUMAN GENOME KONG A; GUDBJARTSSON DF; SAINZ J; JONSDOTTIR GM; GUDJONSSON SA; RICHARDSSON B; SIGURDARDOTTIR S; BARNARD J; HALLBECK B; MASSON G; SHLIEN A; PALSSON ST; FRIGGE ML; THORGEIRSSON TE; GULCHER JR; STEFANSSON K NATURE GENETICS 31: (3) 241-247 JUL 2002 and the citing papers |
Ranked [title] Word (excluding stopwords, and 2-character and smaller words) list
Total: 1014, Word count: 2167, All words count: 3244
View: Overview. Sorted by GCS.
Page 1: 1 2
| # | Word | Pubs | Percent | TLCS | TGCS |
|---|---|---|---|---|---|
| 1 | GENOME | 29 | 11.0 | 348 | 1370 |
| 2 | ANALYSIS | 34 | 12.9 | 48 | 991 |
| 3 | MOUSE | 5 | 1.9 | 29 | 868 |
| 4 | COMPARATIVE | 6 | 2.3 | 35 | 865 |
| 5 | INITIAL | 1 | 0.4 | 24 | 844 |
| 6 | SEQUENCING | 1 | 0.4 | 24 | 844 |
| 7 | HUMAN | 57 | 21.6 | 341 | 651 |
| 8 | RECOMBINATION | 34 | 12.9 | 339 | 514 |
| 9 | MAP | 11 | 4.2 | 273 | 317 |
| 10 | GENE | 28 | 10.6 | 33 | 275 |
| 11 | HIGH-RESOLUTION | 2 | 0.8 | 263 | 263 |
| 12 | CHROMOSOME | 57 | 21.6 | 33 | 249 |
| 13 | SUSCEPTIBILITY | 13 | 4.9 | 19 | 242 |
| 14 | LINKAGE | 49 | 18.6 | 32 | 216 |
| 15 | SCHIZOPHRENIA | 8 | 3.0 | 15 | 195 |
| 16 | EVOLUTION | 10 | 3.8 | 24 | 186 |
| 17 | NEUREGULIN | 1 | 0.4 | 12 | 161 |
| 18 | HAPLOTYPE | 14 | 5.3 | 21 | 148 |
| 19 | SEQUENCE | 12 | 4.5 | 25 | 145 |
| 20 | DISEQUILIBRIUM | 14 | 5.3 | 22 | 142 |
| 21 | MUTATION | 15 | 5.7 | 19 | 120 |
| 22 | VARIATION | 16 | 6.1 | 28 | 108 |
| 23 | DNA | 12 | 4.5 | 13 | 90 |
| 24 | CHROMOSOMES | 11 | 4.2 | 11 | 86 |
| 25 | FREQUENCIES | 3 | 1.1 | 11 | 85 |
| 26 | MAPS | 14 | 5.3 | 19 | 81 |
| 27 | EVIDENCE | 16 | 6.1 | 17 | 77 |
| 28 | BLOCKS | 3 | 1.1 | 12 | 76 |
| 29 | SCAN | 12 | 4.5 | 10 | 70 |
| 30 | HISTORY | 5 | 1.9 | 15 | 66 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 31 | PROTEIN | 5 | 1.9 | 4 | 66 |
| 32 | USING | 10 | 3.8 | 9 | 66 |
| 33 | NOVEL | 16 | 6.1 | 5 | 61 |
| 34 | POPULATION | 9 | 3.4 | 3 | 61 |
| 35 | INFLUENCE | 1 | 0.4 | 14 | 60 |
| 36 | SUBSTITUTION | 2 | 0.8 | 10 | 55 |
| 37 | COVARIATION | 1 | 0.4 | 10 | 54 |
| 38 | DELETION | 1 | 0.4 | 10 | 54 |
| 39 | DISORDER | 12 | 4.5 | 6 | 54 |
| 40 | EUTHERIAN | 1 | 0.4 | 10 | 54 |
| 41 | TRANSPOSITION | 1 | 0.4 | 10 | 54 |
| 42 | MAJOR | 5 | 1.9 | 4 | 53 |
| 43 | HUMANS | 10 | 3.8 | 21 | 52 |
| 44 | LINKED | 6 | 2.3 | 3 | 50 |
| 45 | COMPLEX | 12 | 4.5 | 9 | 49 |
| 46 | DISEASE | 12 | 4.5 | 6 | 49 |
| 47 | STRUCTURE | 4 | 1.5 | 5 | 49 |
| 48 | GENETIC | 30 | 11.4 | 7 | 47 |
| 49 | LOCI | 16 | 6.1 | 2 | 47 |
| 50 | ASSOCIATED | 8 | 3.0 | 0 | 41 |
| 51 | LOCUS | 26 | 9.8 | 3 | 41 |
| 52 | GOALS | 1 | 0.4 | 0 | 40 |
| 53 | NUTRIGENOMICS | 1 | 0.4 | 0 | 40 |
| 54 | RATES | 11 | 4.2 | 16 | 40 |
| 55 | STRATEGIES | 2 | 0.8 | 0 | 40 |
| 56 | POLYMORPHISM | 5 | 1.9 | 12 | 39 |
| 57 | MOLECULAR | 3 | 1.1 | 3 | 38 |
| 58 | RATE | 10 | 3.8 | 13 | 38 |
| 59 | ALLELE | 3 | 1.1 | 2 | 37 |
| 60 | HUMAN-CHIMP-MOUSE | 2 | 0.8 | 2 | 37 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 61 | INFERRING | 1 | 0.4 | 2 | 37 |
| 62 | NONNEUTRAL | 1 | 0.4 | 2 | 37 |
| 63 | ORTHOLOGOUS | 2 | 0.8 | 2 | 37 |
| 64 | RISK | 5 | 1.9 | 3 | 37 |
| 65 | SELECTION | 9 | 3.4 | 8 | 37 |
| 66 | TRIOS | 1 | 0.4 | 2 | 37 |
| 67 | CHROMOSOMAL | 2 | 0.8 | 2 | 35 |
| 68 | DATA | 4 | 1.5 | 1 | 35 |
| 69 | ACCELERATED | 1 | 0.4 | 2 | 34 |
| 70 | ACTIVATING | 1 | 0.4 | 3 | 34 |
| 71 | CONFERS | 1 | 0.4 | 3 | 34 |
| 72 | DIVERGENCE | 1 | 0.4 | 2 | 34 |
| 73 | DIVERSITY | 3 | 1.1 | 14 | 34 |
| 74 | ENCODING | 1 | 0.4 | 3 | 34 |
| 75 | INFARCTION | 1 | 0.4 | 3 | 34 |
| 76 | LIPOXYGENASE | 1 | 0.4 | 3 | 34 |
| 77 | MYOCARDIAL | 1 | 0.4 | 3 | 34 |
| 78 | REARRANGED | 1 | 0.4 | 2 | 34 |
| 79 | SPECIATION | 1 | 0.4 | 2 | 34 |
| 80 | STROKE | 1 | 0.4 | 3 | 34 |
| 81 | ARTHRITIS | 2 | 0.8 | 3 | 33 |
| 82 | CORRELATED | 2 | 0.8 | 1 | 31 |
| 83 | GENOTYPE | 2 | 0.8 | 1 | 31 |
| 84 | INFERENCE | 1 | 0.4 | 1 | 31 |
| 85 | MODEL | 3 | 1.1 | 5 | 31 |
| 86 | MULTILOCUS | 1 | 0.4 | 1 | 31 |
| 87 | SINGLE-NUCLEOTIDE | 5 | 1.9 | 13 | 31 |
| 88 | HIGH-DENSITY | 3 | 1.1 | 4 | 30 |
| 89 | IMPLICATIONS | 4 | 1.5 | 15 | 30 |
| 90 | POPULATIONS | 2 | 0.8 | 3 | 29 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 91 | ASTHMA | 4 | 1.5 | 1 | 28 |
| 92 | BIPOLAR | 6 | 2.3 | 2 | 28 |
| 93 | SPORADIC | 2 | 0.8 | 1 | 28 |
| 94 | MALE | 5 | 1.9 | 7 | 27 |
| 95 | MICROSATELLITE | 5 | 1.9 | 7 | 27 |
| 96 | PRIMATES | 2 | 0.8 | 10 | 27 |
| 97 | ASSOCIATION | 14 | 5.3 | 1 | 26 |
| 98 | CENTROMERE | 4 | 1.5 | 1 | 26 |
| 99 | CORRELATION | 1 | 0.4 | 13 | 26 |
| 100 | EXPLANATION | 1 | 0.4 | 13 | 26 |
| 101 | NEUTRAL | 1 | 0.4 | 13 | 26 |
| 102 | SIGNATURE | 2 | 0.8 | 7 | 26 |
| 103 | FOUNDER | 4 | 1.5 | 1 | 25 |
| 104 | SNPS | 5 | 1.9 | 4 | 25 |
| 105 | WHOLE-GENOME | 4 | 1.5 | 6 | 25 |
| 106 | ASSESSING | 2 | 0.8 | 5 | 24 |
| 107 | BLOCK | 2 | 0.8 | 5 | 24 |
| 108 | FINNISH | 3 | 1.1 | 4 | 24 |
| 109 | GENES | 10 | 3.8 | 5 | 24 |
| 110 | GENOTYPING | 5 | 1.9 | 5 | 24 |
| 111 | MARKERS | 4 | 1.5 | 7 | 24 |
| 112 | PERFORMANCE | 1 | 0.4 | 5 | 24 |
| 113 | TYPE | 7 | 2.7 | 1 | 24 |
| 114 | ARRAY | 2 | 0.8 | 4 | 23 |
| 115 | ASSAY | 1 | 0.4 | 4 | 23 |
| 116 | DIFFERENT | 3 | 1.1 | 3 | 23 |
| 117 | GENOMEWIDE | 8 | 3.0 | 3 | 23 |
| 118 | MUTATIONS | 6 | 2.3 | 0 | 23 |
| 119 | OLIGONUCLEOTIDE | 1 | 0.4 | 4 | 23 |
| 120 | ONE-PRIMER | 1 | 0.4 | 4 | 23 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 121 | PARALLEL | 1 | 0.4 | 4 | 23 |
| 122 | CONSERVED | 1 | 0.4 | 0 | 22 |
| 123 | EFFECT | 4 | 1.5 | 0 | 22 |
| 124 | ENCODES | 1 | 0.4 | 0 | 22 |
| 125 | ESSENTIAL | 1 | 0.4 | 0 | 22 |
| 126 | HYPERTENSION | 1 | 0.4 | 0 | 22 |
| 127 | MUTATED | 1 | 0.4 | 0 | 22 |
| 128 | NEPHRONOPHTHISIS | 1 | 0.4 | 0 | 22 |
| 129 | NEPHRORETININ | 1 | 0.4 | 0 | 22 |
| 130 | PAIRS | 5 | 1.9 | 2 | 22 |
| 131 | PIGMENTOSA | 1 | 0.4 | 0 | 22 |
| 132 | RETINITIS | 1 | 0.4 | 0 | 22 |
| 133 | ASHKENAZI | 3 | 1.1 | 1 | 21 |
| 134 | AUTOSOME | 1 | 0.4 | 5 | 21 |
| 135 | IDENTIFIED | 1 | 0.4 | 5 | 21 |
| 136 | META-ANALYSIS | 1 | 0.4 | 2 | 21 |
| 137 | METHODS | 2 | 0.8 | 2 | 21 |
| 138 | PAINTING | 1 | 0.4 | 5 | 21 |
| 139 | PART | 1 | 0.4 | 2 | 21 |
| 140 | POWER | 1 | 0.4 | 2 | 21 |
| 141 | THIOREDOXIN | 3 | 1.1 | 3 | 21 |
| 142 | FINE-SCALE | 3 | 1.1 | 5 | 20 |
| 143 | JEWISH | 3 | 1.1 | 1 | 20 |
| 144 | SIB | 2 | 0.8 | 2 | 20 |
| 145 | BIASED | 2 | 0.8 | 7 | 19 |
| 146 | CONVERSION | 2 | 0.8 | 7 | 19 |
| 147 | HEREDITARY | 3 | 1.1 | 1 | 19 |
| 148 | HOT | 3 | 1.1 | 9 | 19 |
| 149 | IMPRINTING | 1 | 0.4 | 3 | 19 |
| 150 | INTERVAL | 2 | 0.8 | 3 | 19 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 151 | MAPPING | 16 | 6.1 | 0 | 19 |
| 152 | NUCLEOTIDE | 5 | 1.9 | 6 | 19 |
| 153 | PATTERNS | 7 | 2.7 | 1 | 19 |
| 154 | PSORIATIC | 1 | 0.4 | 3 | 19 |
| 155 | SEX | 3 | 1.1 | 7 | 19 |
| 156 | SPOTS | 2 | 0.8 | 9 | 19 |
| 157 | ANCESTRAL | 3 | 1.1 | 0 | 18 |
| 158 | SNP | 2 | 0.8 | 3 | 18 |
| 159 | ACHIEVED | 1 | 0.4 | 9 | 17 |
| 160 | CANCER | 2 | 0.8 | 1 | 17 |
| 161 | CAUSE | 1 | 0.4 | 1 | 17 |
| 162 | COLD | 2 | 0.8 | 9 | 17 |
| 163 | COLORECTAL | 1 | 0.4 | 1 | 17 |
| 164 | DETECTED | 1 | 0.4 | 3 | 17 |
| 165 | FIND | 1 | 0.4 | 9 | 17 |
| 166 | HISTOCOMPATIBILITY | 1 | 0.4 | 3 | 17 |
| 167 | HISTORIES | 1 | 0.4 | 3 | 17 |
| 168 | HYPERACTIVITY | 2 | 0.8 | 2 | 17 |
| 169 | IMPORTANT | 1 | 0.4 | 1 | 17 |
| 170 | INTEGRATED | 1 | 0.4 | 3 | 17 |
| 171 | MSH2*1906G | 1 | 0.4 | 1 | 17 |
| 172 | NONPOLYPOSIS | 1 | 0.4 | 1 | 17 |
| 173 | REASON | 1 | 0.4 | 9 | 17 |
| 174 | SUBSET | 2 | 0.8 | 1 | 17 |
| 175 | SUGGESTIVE | 2 | 0.8 | 2 | 17 |
| 176 | DUTCH | 5 | 1.9 | 2 | 16 |
| 177 | FAMILIES | 9 | 3.4 | 1 | 16 |
| 178 | GENETICS | 4 | 1.5 | 2 | 16 |
| 179 | GENOMIC | 6 | 2.3 | 0 | 16 |
| 180 | HOTSPOT | 2 | 0.8 | 10 | 16 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 181 | LARGE | 3 | 1.1 | 1 | 16 |
| 182 | OSTEOARTHRITIS | 3 | 1.1 | 2 | 16 |
| 183 | SCREENING | 2 | 0.8 | 6 | 16 |
| 184 | VARIABILITY | 2 | 0.8 | 6 | 16 |
| 185 | ATTENTION-DEFICIT | 1 | 0.4 | 2 | 15 |
| 186 | BETA-GLOBIN | 1 | 0.4 | 10 | 15 |
| 187 | EXPRESSION | 7 | 2.7 | 2 | 15 |
| 188 | G6PD | 1 | 0.4 | 5 | 15 |
| 189 | LINKAGE-DISEQUILIBRIUM | 1 | 0.4 | 10 | 15 |
| 190 | MALARIAL | 1 | 0.4 | 5 | 15 |
| 191 | MEIOTIC | 6 | 2.3 | 6 | 15 |
| 192 | MOSAIC | 2 | 0.8 | 3 | 15 |
| 193 | PARKINSON | 2 | 0.8 | 1 | 15 |
| 194 | REGION | 6 | 2.3 | 1 | 15 |
| 195 | .9-CENTIMORGAN-RESOLUTION | 1 | 0.4 | 6 | 14 |
| 196 | ACCOUNT | 1 | 0.4 | 1 | 14 |
| 197 | ALPHA-TUMOR | 1 | 0.4 | 0 | 14 |
| 198 | APPARENTLY | 1 | 0.4 | 1 | 14 |
| 199 | CARCINOMA | 1 | 0.4 | 1 | 14 |
| 200 | CASES | 1 | 0.4 | 1 | 14 |
| 201 | FACTOR | 2 | 0.8 | 0 | 14 |
| 202 | FOUNDING | 1 | 0.4 | 1 | 14 |
| 203 | HAND | 1 | 0.4 | 2 | 14 |
| 204 | HIRSCHSPRUNG | 1 | 0.4 | 1 | 14 |
| 205 | HLA-DR | 1 | 0.4 | 0 | 14 |
| 206 | HRPT | 1 | 0.4 | 0 | 14 |
| 207 | INFLUENCED | 1 | 0.4 | 0 | 14 |
| 208 | LYMPHOTOXIN | 1 | 0.4 | 0 | 14 |
| 209 | MALIGNANCY | 1 | 0.4 | 0 | 14 |
| 210 | MATRILIN | 1 | 0.4 | 2 | 14 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 211 | MAY | 2 | 0.8 | 1 | 14 |
| 212 | MEDULLARY | 1 | 0.4 | 1 | 14 |
| 213 | NECROSIS | 1 | 0.4 | 0 | 14 |
| 214 | PARATHYROID | 1 | 0.4 | 0 | 14 |
| 215 | POLYMORPHISMS | 7 | 2.7 | 4 | 14 |
| 216 | PROPORTION | 1 | 0.4 | 1 | 14 |
| 217 | PROTO-ONCOGENE | 1 | 0.4 | 1 | 14 |
| 218 | RET | 1 | 0.4 | 1 | 14 |
| 219 | RHEUMATOID | 1 | 0.4 | 0 | 14 |
| 220 | SET | 1 | 0.4 | 6 | 14 |
| 221 | THYROID | 2 | 0.8 | 1 | 14 |
| 222 | TUMOURS | 1 | 0.4 | 0 | 14 |
| 223 | AIRWAY | 1 | 0.4 | 2 | 13 |
| 224 | AXONEME | 1 | 0.4 | 2 | 13 |
| 225 | CHARACTERIZATION | 1 | 0.4 | 2 | 13 |
| 226 | CILIA | 1 | 0.4 | 2 | 13 |
| 227 | EPITHELIUM | 1 | 0.4 | 2 | 13 |
| 228 | EXPRESSED | 1 | 0.4 | 2 | 13 |
| 229 | HAPLOTYPES | 4 | 1.5 | 1 | 13 |
| 230 | LUNG | 2 | 0.8 | 2 | 13 |
| 231 | MANCHETTE | 1 | 0.4 | 2 | 13 |
| 232 | MICROTUBULE-BINDING | 1 | 0.4 | 2 | 13 |
| 233 | PREDOMINANTLY | 1 | 0.4 | 2 | 13 |
| 234 | Q36 | 1 | 0.4 | 1 | 13 |
| 235 | SIGNIFICANT | 3 | 1.1 | 1 | 13 |
| 236 | SPERMATID | 1 | 0.4 | 2 | 13 |
| 237 | THIOREDOXIN-LIKE | 1 | 0.4 | 2 | 13 |
| 238 | ASPM | 2 | 0.8 | 0 | 12 |
| 239 | BRAIN | 1 | 0.4 | 0 | 12 |
| 240 | DETERMINANT | 1 | 0.4 | 0 | 12 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 241 | DUPLICONS | 1 | 0.4 | 0 | 12 |
| 242 | EUROPEAN | 3 | 1.1 | 0 | 12 |
| 243 | FLANKED | 1 | 0.4 | 0 | 12 |
| 244 | NEOCENTROMERES | 1 | 0.4 | 0 | 12 |
| 245 | PHYLOGENY | 2 | 0.8 | 0 | 12 |
| 246 | Q24 | 1 | 0.4 | 0 | 12 |
| 247 | REPOSITIONING | 1 | 0.4 | 0 | 12 |
| 248 | SIZE | 1 | 0.4 | 0 | 12 |
| 249 | CLONING | 2 | 0.8 | 2 | 11 |
| 250 | DESIGNS | 2 | 0.8 | 0 | 11 |
| 251 | DISTRIBUTION | 4 | 1.5 | 6 | 11 |
| 252 | DYSTROPHY | 2 | 0.8 | 2 | 11 |
| 253 | EXTENSIVE | 2 | 0.8 | 0 | 11 |
| 254 | MEDIATED | 1 | 0.4 | 2 | 11 |
| 255 | SITES | 1 | 0.4 | 6 | 11 |
| 256 | FAMILIAL | 3 | 1.1 | 0 | 10 |
| 257 | MIGRAINE | 2 | 0.8 | 1 | 10 |
| 258 | PATTERN | 1 | 0.4 | 3 | 10 |
| 259 | SYSTEMATIC | 2 | 0.8 | 0 | 10 |
| 260 | AMERICANS | 2 | 0.8 | 0 | 9 |
| 261 | ANXIETY | 1 | 0.4 | 2 | 9 |
| 262 | COMPARISON | 2 | 0.8 | 4 | 9 |
| 263 | DIABETES | 3 | 1.1 | 1 | 9 |
| 264 | ICELAND | 1 | 0.4 | 2 | 9 |
| 265 | ISOCHORES | 2 | 0.8 | 1 | 9 |
| 266 | LATE-ONSET | 2 | 0.8 | 0 | 9 |
| 267 | MICROSATELLITES | 4 | 1.5 | 4 | 9 |
| 268 | ORIGIN | 3 | 1.1 | 1 | 9 |
| 269 | PANIC | 1 | 0.4 | 2 | 9 |
| 270 | SINGLE | 4 | 1.5 | 0 | 9 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 271 | TISSUE-SPECIFICITY | 1 | 0.4 | 1 | 9 |
| 272 | ALIGNMENTS | 2 | 0.8 | 0 | 8 |
| 273 | ANNOTATIONS | 1 | 0.4 | 0 | 8 |
| 274 | AUTOANTIGEN | 1 | 0.4 | 1 | 8 |
| 275 | BIOLOGY | 1 | 0.4 | 2 | 8 |
| 276 | DATABASE | 1 | 0.4 | 0 | 8 |
| 277 | DEVELOPMENTAL | 1 | 0.4 | 1 | 8 |
| 278 | DYSTROPHIN | 1 | 0.4 | 1 | 8 |
| 279 | FIBROUS | 1 | 0.4 | 1 | 8 |
| 280 | GALA | 1 | 0.4 | 0 | 8 |
| 281 | GENOME-WIDE | 9 | 3.4 | 0 | 8 |
| 282 | GENOMES | 2 | 0.8 | 0 | 8 |
| 283 | IDENTIFICATION | 6 | 2.3 | 0 | 8 |
| 284 | INFANTILE | 2 | 0.8 | 0 | 8 |
| 285 | LOCALIZATION | 4 | 1.5 | 2 | 8 |
| 286 | MODERN | 1 | 0.4 | 1 | 8 |
| 287 | MURID | 1 | 0.4 | 1 | 8 |
| 288 | POINT | 1 | 0.4 | 1 | 8 |
| 289 | POSITIVE | 3 | 1.1 | 1 | 8 |
| 290 | SEGMENT | 2 | 0.8 | 1 | 8 |
| 291 | SHEATH | 1 | 0.4 | 1 | 8 |
| 292 | SPERM | 2 | 0.8 | 1 | 8 |
| 293 | SPERMATID-SPECIFIC | 2 | 0.8 | 1 | 8 |
| 294 | SPTRX | 1 | 0.4 | 1 | 8 |
| 295 | TIME | 2 | 0.8 | 1 | 8 |
| 296 | .9MB | 1 | 0.4 | 0 | 7 |
| 297 | ADMIXTURE | 1 | 0.4 | 0 | 7 |
| 298 | AFRICAN | 1 | 0.4 | 0 | 7 |
| 299 | AGE-RELATED | 1 | 0.4 | 0 | 7 |
| 300 | CEREBRAL | 1 | 0.4 | 0 | 7 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 301 | CHIMPANZEES | 2 | 0.8 | 1 | 7 |
| 302 | COLLAGEN | 1 | 0.4 | 0 | 7 |
| 303 | CONFIRMATION | 4 | 1.5 | 0 | 7 |
| 304 | CTRP | 1 | 0.4 | 0 | 7 |
| 305 | DEGENERATION | 2 | 0.8 | 0 | 7 |
| 306 | DEPOSIT | 1 | 0.4 | 0 | 7 |
| 307 | DISCOVERY | 1 | 0.4 | 0 | 7 |
| 308 | EXTRACELLULAR | 1 | 0.4 | 0 | 7 |
| 309 | FIXATION | 2 | 0.8 | 1 | 7 |
| 310 | FORMATION | 1 | 0.4 | 0 | 7 |
| 311 | HEMIPLEGIC | 1 | 0.4 | 0 | 7 |
| 312 | INDICATES | 2 | 0.8 | 0 | 7 |
| 313 | LACTASE | 1 | 0.4 | 1 | 7 |
| 314 | MACULAR | 1 | 0.4 | 0 | 7 |
| 315 | MALARIA | 1 | 0.4 | 0 | 7 |
| 316 | MULTIPLE | 5 | 1.9 | 0 | 7 |
| 317 | PATIENTS | 3 | 1.1 | 0 | 7 |
| 318 | PREECLAMPSIA | 1 | 0.4 | 1 | 7 |
| 319 | PROTECTION | 1 | 0.4 | 0 | 7 |
| 320 | RECENT | 2 | 0.8 | 1 | 7 |
| 321 | RESULTS | 3 | 1.1 | 0 | 7 |
| 322 | RETINAL | 1 | 0.4 | 0 | 7 |
| 323 | SHORT-CHAIN | 1 | 0.4 | 0 | 7 |
| 324 | SIGNATURES | 1 | 0.4 | 1 | 7 |
| 325 | STRONG | 1 | 0.4 | 1 | 7 |
| 326 | STRUCTURES | 1 | 0.4 | 2 | 7 |
| 327 | TRAITS | 3 | 1.1 | 1 | 7 |
| 328 | UNIFICATION | 1 | 0.4 | 2 | 7 |
| 329 | BASIS | 2 | 0.8 | 1 | 6 |
| 330 | BENEFICIAL | 1 | 0.4 | 1 | 6 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 331 | CASE-CONTROL | 1 | 0.4 | 0 | 6 |
| 332 | CCTG | 1 | 0.4 | 0 | 6 |
| 333 | DEMOGRAPHIC | 1 | 0.4 | 1 | 6 |
| 334 | DISEASES | 3 | 1.1 | 0 | 6 |
| 335 | DRIVES | 1 | 0.4 | 2 | 6 |
| 336 | ESTIMATING | 2 | 0.8 | 1 | 6 |
| 337 | EXPANSION | 1 | 0.4 | 0 | 6 |
| 338 | FINE | 4 | 1.5 | 0 | 6 |
| 339 | GC-CONTENT | 1 | 0.4 | 2 | 6 |
| 340 | MAMMALIAN | 2 | 0.8 | 0 | 6 |
| 341 | MYOPATHY | 1 | 0.4 | 0 | 6 |
| 342 | MYOTONIC | 1 | 0.4 | 0 | 6 |
| 343 | ORIGINS | 1 | 0.4 | 0 | 6 |
| 344 | POPULATION-GENETIC | 1 | 0.4 | 1 | 6 |
| 345 | PROXIMAL | 1 | 0.4 | 0 | 6 |
| 346 | SHARED | 1 | 0.4 | 0 | 6 |
| 347 | SUBSTANTIAL | 1 | 0.4 | 1 | 6 |
| 348 | TRAFFIC | 1 | 0.4 | 0 | 6 |
| 349 | VARIANT | 2 | 0.8 | 0 | 6 |
| 350 | ASPHYXIATING | 1 | 0.4 | 2 | 5 |
| 351 | ATD | 1 | 0.4 | 2 | 5 |
| 352 | COALESCENT | 2 | 0.8 | 1 | 5 |
| 353 | COLOR | 1 | 0.4 | 0 | 5 |
| 354 | COST-EFFECTIVE | 1 | 0.4 | 0 | 5 |
| 355 | CROSSOVERS | 1 | 0.4 | 1 | 5 |
| 356 | DISTORTION | 1 | 0.4 | 0 | 5 |
| 357 | DISTRIBUTIONS | 1 | 0.4 | 1 | 5 |
| 358 | EFFECTS | 3 | 1.1 | 1 | 5 |
| 359 | EVOLUTIONARY | 1 | 0.4 | 1 | 5 |
| 360 | EYE | 1 | 0.4 | 0 | 5 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 361 | FASTER | 1 | 0.4 | 1 | 5 |
| 362 | GENEALOGIES | 2 | 0.8 | 1 | 5 |
| 363 | HIGH | 3 | 1.1 | 2 | 5 |
| 364 | ICELANDIC | 1 | 0.4 | 1 | 5 |
| 365 | LINEAGES | 1 | 0.4 | 1 | 5 |
| 366 | MAMMALS | 2 | 0.8 | 1 | 5 |
| 367 | MATRILINEAL | 1 | 0.4 | 1 | 5 |
| 368 | MTDNA | 1 | 0.4 | 1 | 5 |
| 369 | NUMBER | 1 | 0.4 | 0 | 5 |
| 370 | PATRILINEAL | 1 | 0.4 | 1 | 5 |
| 371 | PEDIGREES | 2 | 0.8 | 0 | 5 |
| 372 | POPULATIONWIDE | 1 | 0.4 | 1 | 5 |
| 373 | Q34-Q35. | 1 | 0.4 | 1 | 5 |
| 374 | QTL | 2 | 0.8 | 0 | 5 |
| 375 | REGIONS | 5 | 1.9 | 0 | 5 |
| 376 | RELATIONSHIP | 1 | 0.4 | 0 | 5 |
| 377 | REPEAT | 1 | 0.4 | 0 | 5 |
| 378 | SLIPPAGE | 1 | 0.4 | 0 | 5 |
| 379 | THORACIC | 1 | 0.4 | 2 | 5 |
| 380 | TRANSMISSION | 1 | 0.4 | 0 | 5 |
| 381 | TWIN | 1 | 0.4 | 0 | 5 |
| 382 | UNITS | 1 | 0.4 | 0 | 5 |
| 383 | VARIANTS | 5 | 1.9 | 0 | 5 |
| 384 | ACCURATE | 1 | 0.4 | 3 | 4 |
| 385 | ALLELIC | 1 | 0.4 | 0 | 4 |
| 386 | APPLIED | 1 | 0.4 | 0 | 4 |
| 387 | BACTERIAL | 1 | 0.4 | 0 | 4 |
| 388 | CAPILLARY | 1 | 0.4 | 0 | 4 |
| 389 | CAUCASIANS | 1 | 0.4 | 0 | 4 |
| 390 | CEROLID | 1 | 0.4 | 0 | 4 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 391 | CLN | 1 | 0.4 | 0 | 4 |
| 392 | CONDITIONAL | 1 | 0.4 | 0 | 4 |
| 393 | DECODE | 1 | 0.4 | 1 | 4 |
| 394 | DISORDERS | 3 | 1.1 | 0 | 4 |
| 395 | DISTANCES | 1 | 0.4 | 3 | 4 |
| 396 | DNA-LABELING | 1 | 0.4 | 0 | 4 |
| 397 | ENERGY | 1 | 0.4 | 0 | 4 |
| 398 | FIBROMATOSIS | 1 | 0.4 | 0 | 4 |
| 399 | FLUORESCEIN | 1 | 0.4 | 0 | 4 |
| 400 | FLUORESCENCE | 1 | 0.4 | 0 | 4 |
| 401 | FLUOROPHORE | 1 | 0.4 | 0 | 4 |
| 402 | HEALTH | 1 | 0.4 | 0 | 4 |
| 403 | HYALINE | 1 | 0.4 | 0 | 4 |
| 404 | HYALINOSIS | 1 | 0.4 | 0 | 4 |
| 405 | INC | 1 | 0.4 | 1 | 4 |
| 406 | INDIVIDUAL | 1 | 0.4 | 2 | 4 |
| 407 | INITIATIVE | 1 | 0.4 | 0 | 4 |
| 408 | INSTITUTE | 1 | 0.4 | 0 | 4 |
| 409 | INTERACTION | 1 | 0.4 | 0 | 4 |
| 410 | INTERCALATOR | 1 | 0.4 | 0 | 4 |
| 411 | ISOTHIOCYANATE | 1 | 0.4 | 0 | 4 |
| 412 | JUVENILE | 1 | 0.4 | 0 | 4 |
| 413 | LATE | 1 | 0.4 | 0 | 4 |
| 414 | LIPOFUSCINOSIS | 1 | 0.4 | 0 | 4 |
| 415 | MAGNETIC | 1 | 0.4 | 0 | 4 |
| 416 | MENTAL | 1 | 0.4 | 0 | 4 |
| 417 | METRIC | 1 | 0.4 | 1 | 4 |
| 418 | MORPHOGENESIS | 1 | 0.4 | 0 | 4 |
| 419 | NATIONAL | 1 | 0.4 | 0 | 4 |
| 420 | NEURONAL | 1 | 0.4 | 0 | 4 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 421 | NORTHERN | 1 | 0.4 | 0 | 4 |
| 422 | PARTICLES | 1 | 0.4 | 0 | 4 |
| 423 | POPO | 1 | 0.4 | 0 | 4 |
| 424 | PSEUDOAUTOSOMAL | 2 | 0.8 | 2 | 4 |
| 425 | Q21-Q | 1 | 0.4 | 0 | 4 |
| 426 | RESONANCE | 1 | 0.4 | 0 | 4 |
| 427 | RESULT | 1 | 0.4 | 0 | 4 |
| 428 | SAMPLING | 3 | 1.1 | 0 | 4 |
| 429 | SPECTRUM | 1 | 0.4 | 0 | 4 |
| 430 | SYSTEMIC | 2 | 0.8 | 0 | 4 |
| 431 | THEORY | 1 | 0.4 | 0 | 4 |
| 432 | TRANSFER | 1 | 0.4 | 0 | 4 |
| 433 | AFFECTIVE | 3 | 1.1 | 0 | 3 |
| 434 | ALTERATIONS | 1 | 0.4 | 0 | 3 |
| 435 | AMAUROSIS | 1 | 0.4 | 0 | 3 |
| 436 | APE | 1 | 0.4 | 2 | 3 |
| 437 | ASTHMA-RELATED | 1 | 0.4 | 0 | 3 |
| 438 | AURA | 1 | 0.4 | 1 | 3 |
| 439 | AUTISM | 2 | 0.8 | 0 | 3 |
| 440 | CARD | 1 | 0.4 | 0 | 3 |
| 441 | CAUSING | 2 | 0.8 | 0 | 3 |
| 442 | CONGENITAL | 1 | 0.4 | 0 | 3 |
| 443 | CROHN | 1 | 0.4 | 0 | 3 |
| 444 | DEMONSTRATES | 1 | 0.4 | 0 | 3 |
| 445 | DFNA | 3 | 1.1 | 0 | 3 |
| 446 | DISEASE-ASSOCIATED | 1 | 0.4 | 0 | 3 |
| 447 | FAMILY | 4 | 1.5 | 0 | 3 |
| 448 | FASHION | 1 | 0.4 | 1 | 3 |
| 449 | FEMALES | 2 | 0.8 | 0 | 3 |
| 450 | HARBORS | 1 | 0.4 | 0 | 3 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 451 | IBD | 2 | 0.8 | 0 | 3 |
| 452 | INSIGHTS | 1 | 0.4 | 1 | 3 |
| 453 | INTERACTIONS | 1 | 0.4 | 0 | 3 |
| 454 | KINDRED | 3 | 1.1 | 0 | 3 |
| 455 | LCA | 1 | 0.4 | 0 | 3 |
| 456 | LEBER | 1 | 0.4 | 0 | 3 |
| 457 | MATTER | 1 | 0.4 | 1 | 3 |
| 458 | MYOSIN | 2 | 0.8 | 0 | 3 |
| 459 | OBESITY | 2 | 0.8 | 0 | 3 |
| 460 | PARENT-OF-ORIGIN | 2 | 0.8 | 1 | 3 |
| 461 | PHENOTYPES | 1 | 0.4 | 0 | 3 |
| 462 | POSITIONAL | 1 | 0.4 | 1 | 3 |
| 463 | RAT | 1 | 0.4 | 0 | 3 |
| 464 | RECEPTOR | 3 | 1.1 | 0 | 3 |
| 465 | RELATED | 2 | 0.8 | 0 | 3 |
| 466 | RIGID-COMPULSIVE | 1 | 0.4 | 0 | 3 |
| 467 | SEROTONIN | 1 | 0.4 | 0 | 3 |
| 468 | SHOWS | 1 | 0.4 | 0 | 3 |
| 469 | SLC6A | 1 | 0.4 | 0 | 3 |
| 470 | TRANSPORTER | 2 | 0.8 | 0 | 3 |
| 471 | TUMORS | 1 | 0.4 | 0 | 3 |
| 472 | TWO | 5 | 1.9 | 1 | 3 |
| 473 | ANCIENT | 1 | 0.4 | 0 | 2 |
| 474 | ANDROGENETIC | 1 | 0.4 | 0 | 2 |
| 475 | APPROACHES | 4 | 1.5 | 1 | 2 |
| 476 | ARCHITECTURE | 2 | 0.8 | 0 | 2 |
| 477 | ARISES | 1 | 0.4 | 0 | 2 |
| 478 | ARSENIC | 1 | 0.4 | 0 | 2 |
| 479 | ATTENTION | 1 | 0.4 | 0 | 2 |
| 480 | AUTONOMIC | 1 | 0.4 | 0 | 2 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 481 | AUTOSOMAL | 4 | 1.5 | 0 | 2 |
| 482 | CANADIAN | 1 | 0.4 | 0 | 2 |
| 483 | CANDIDATE | 2 | 0.8 | 0 | 2 |
| 484 | CARNEY | 1 | 0.4 | 0 | 2 |
| 485 | CHAIN | 1 | 0.4 | 0 | 2 |
| 486 | CLOSE | 1 | 0.4 | 0 | 2 |
| 487 | CLUSTERED | 1 | 0.4 | 0 | 2 |
| 488 | COINCIDES | 1 | 0.4 | 0 | 2 |
| 489 | CUBAN | 1 | 0.4 | 0 | 2 |
| 490 | DEFICIT | 1 | 0.4 | 0 | 2 |
| 491 | DELETIONS | 1 | 0.4 | 0 | 2 |
| 492 | DENSITY | 1 | 0.4 | 0 | 2 |
| 493 | DOMINANT | 2 | 0.8 | 0 | 2 |
| 494 | DOPAMINE | 1 | 0.4 | 0 | 2 |
| 495 | DOWN-REGULATED | 1 | 0.4 | 0 | 2 |
| 496 | DRD | 1 | 0.4 | 0 | 2 |
| 497 | EVR | 1 | 0.4 | 0 | 2 |
| 498 | EXUDATIVE | 1 | 0.4 | 0 | 2 |
| 499 | FEVR | 1 | 0.4 | 0 | 2 |
| 500 | FOUNDERS | 1 | 0.4 | 0 | 2 |
| 501 | FOURTH | 1 | 0.4 | 0 | 2 |
| 502 | FUNCTIONAL | 3 | 1.1 | 0 | 2 |
| 503 | GLUTATHIONE | 1 | 0.4 | 0 | 2 |
| 504 | HEAVY | 1 | 0.4 | 0 | 2 |
| 505 | HSN | 1 | 0.4 | 0 | 2 |
| 506 | INDIGENOUS | 1 | 0.4 | 0 | 2 |
| 507 | INFLUENCES | 2 | 0.8 | 0 | 2 |
| 508 | INSERTIONS | 1 | 0.4 | 0 | 2 |
| 509 | INTEGRATION | 2 | 0.8 | 2 | 2 |
| 510 | ISLANDS | 3 | 1.1 | 0 | 2 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 511 | ISOLATES | 3 | 1.1 | 0 | 2 |
| 512 | LACK | 1 | 0.4 | 0 | 2 |
| 513 | LARGE-SCALE | 1 | 0.4 | 2 | 2 |
| 514 | LEFT | 1 | 0.4 | 0 | 2 |
| 515 | MASS | 2 | 0.8 | 0 | 2 |
| 516 | MATERNAL | 1 | 0.4 | 0 | 2 |
| 517 | METABOLISM | 1 | 0.4 | 0 | 2 |
| 518 | N88K | 1 | 0.4 | 0 | 2 |
| 519 | NEUROPATHY | 1 | 0.4 | 0 | 2 |
| 520 | NUCLEOSIDE | 1 | 0.4 | 0 | 2 |
| 521 | OFFSPRING | 1 | 0.4 | 0 | 2 |
| 522 | OMEGA | 1 | 0.4 | 0 | 2 |
| 523 | OPTIMISM | 1 | 0.4 | 0 | 2 |
| 524 | PATERNAL | 1 | 0.4 | 0 | 2 |
| 525 | PERINATAL | 1 | 0.4 | 0 | 2 |
| 526 | PHOSPHORYLASE | 1 | 0.4 | 0 | 2 |
| 527 | PHYSICAL | 1 | 0.4 | 2 | 2 |
| 528 | PLACENTAS | 1 | 0.4 | 0 | 2 |
| 529 | PRE-ECLAMPTIC | 1 | 0.4 | 0 | 2 |
| 530 | PUBERTAL | 1 | 0.4 | 1 | 2 |
| 531 | PURINE | 1 | 0.4 | 0 | 2 |
| 532 | Q25. | 1 | 0.4 | 0 | 2 |
| 533 | RAPSYN | 1 | 0.4 | 0 | 2 |
| 534 | REDUCES | 1 | 0.4 | 0 | 2 |
| 535 | RODENTS | 1 | 0.4 | 0 | 2 |
| 536 | S-TRANSFERASE | 1 | 0.4 | 0 | 2 |
| 537 | SAMPLE | 2 | 0.8 | 0 | 2 |
| 538 | SCLEROSIS | 2 | 0.8 | 0 | 2 |
| 539 | SCREEN | 2 | 0.8 | 0 | 2 |
| 540 | SECOND | 1 | 0.4 | 0 | 2 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 541 | SELECTED | 1 | 0.4 | 0 | 2 |
| 542 | SENSORY | 1 | 0.4 | 0 | 2 |
| 543 | SETS | 1 | 0.4 | 0 | 2 |
| 544 | SIBLING | 3 | 1.1 | 0 | 2 |
| 545 | STATURE | 1 | 0.4 | 1 | 2 |
| 546 | STOPS | 1 | 0.4 | 0 | 2 |
| 547 | STRP | 1 | 0.4 | 0 | 2 |
| 548 | SUPPORTS | 3 | 1.1 | 0 | 2 |
| 549 | SWEDISH | 1 | 0.4 | 0 | 2 |
| 550 | TIMING | 1 | 0.4 | 1 | 2 |
| 551 | TOO | 1 | 0.4 | 0 | 2 |
| 552 | TWINS | 1 | 0.4 | 0 | 2 |
| 553 | VENTRICULAR | 1 | 0.4 | 0 | 2 |
| 554 | VITREORETINOPATHY | 1 | 0.4 | 0 | 2 |
| 555 | X-Y | 1 | 0.4 | 0 | 2 |
| 556 | ABO | 1 | 0.4 | 0 | 1 |
| 557 | ABSENCE | 1 | 0.4 | 0 | 1 |
| 558 | AFFECTED | 4 | 1.5 | 0 | 1 |
| 559 | AFFECTING | 1 | 0.4 | 0 | 1 |
| 560 | AFRICA | 1 | 0.4 | 1 | 1 |
| 561 | AGE | 1 | 0.4 | 0 | 1 |
| 562 | ALAS | 1 | 0.4 | 1 | 1 |
| 563 | ALCOHOL | 2 | 0.8 | 0 | 1 |
| 564 | ALLELES | 1 | 0.4 | 0 | 1 |
| 565 | ALOPECIA | 1 | 0.4 | 0 | 1 |
| 566 | ALPHA | 2 | 0.8 | 0 | 1 |
| 567 | ANTAGONIST | 1 | 0.4 | 0 | 1 |
| 568 | AREATA | 1 | 0.4 | 0 | 1 |
| 569 | BIASES | 1 | 0.4 | 0 | 1 |
| 570 | BLOCK-FREE | 1 | 0.4 | 0 | 1 |
| # | Word | Pubs | Percent | TLCS | TGCS |
| 571 | BLOOD | 1 | 0.4 | 0 | 1 |
| 572 | BMP | 1 | 0.4 | 0 | 1 |
| 573 | CANCER-SUSCEPTIBILITY | 1 | 0.4 | 0 | 1 |
| 574 | CATARACTS | 1 | 0.4 | 0 | 1 |
| 575 | CEPH | 1 | 0.4 | 0 | 1 |
| 576 | CHROMOGRANIN | 1 | 0.4 | 0 | 1 |
| 577 | CLINICAL | 1 | 0.4 | 0 | 1 |
| 578 | COMBINATORIAL | 1 | 0.4 | 0 | 1 |
| 579 | COMMON | 3 | 1.1 | 0 | 1 |
| 580 | CONCORDANT | 1 | 0.4 | 0 | 1 |
| 581 | CONSANGUINEOUS | 2 | 0.8 | 0 | 1 |
| 582 | CPG | 1 | 0.4 | 0 | 1 |
| 583 | CYTOLOGICAL | 1 | 0.4 | 0 | 1 |
| 584 | DEPENDENCE | 2 | 0.8 | 0 | 1 |
| 585 | DISCORDANT | 1 | 0.4 | 0 | 1 |
| 586 | DISJOINED | 1 | 0.4 | 0 | 1 |
| 587 | DOMAIN | 1 | 0.4 | 0 | 1 |
| 588 | DRIFT | 1 | 0.4 | 0 | 1 |
| 589 | DYNAMICS | 1 | 0.4 | 0 | 1 |
| 590 | EIF2AK | 1 | 0.4 | 0 | 1 |
| 591 | EMERGING | 1 | 0.4 | 0 | 1 |
| 592 | EPIGENOMICS | 1 | 0.4 | 0 | 1 |
| 593 | EXOCYTOTIC | 1 | 0.4 | 0 | 1 |
| 594 | EXTREMELY | 1 | 0.4 | 0 | 1 |
| 595 | FAROE | 2 | 0.8 | 0 | 1 |
| 596 | FINER | 1 | 0.4 | 0 | 1 |
| 597 | FLANKING | 1 | 0.4 | 1 | 1 |
| 598 | FORM | 3 | 1.1 | 0 | 1 |
| 599 | FRIZZLED-RELATED | 1 | 0.4 | 0 | 1 |
| 600 | GAP-JUNCTION | 1 | 0.4 | 0 | 1 |
Page 1: 1 2